Management of inflammatory bowel disease during COVID-19 pandemic

Minerva Gastroenterol Dietol. 2020 Sep;66(3):184-186. doi: 10.23736/S1121-421X.20.02707-5. Epub 2020 Apr 23.

Authors

Davide G Ribaldone¹, Marco Astegiano², Giovanni C Actis³, Rinaldo Pellicano²

Affiliations

¹ Division of Gastroenterology, Department of Medical Sciences, University of Turin, Turin, Italy - davrib_1998@yahoo.com.
² Unit of Gastroenterology, Molinette-SGAS Hospital, Città della Salute e della Scienza, Turin, Italy.
³ The Medical Center Practice Office, Turin, Italy.

PMID: 32327626
DOI: 10.23736/S1121-421X.20.02707-5

No abstract available

Publication types

Editorial

MeSH terms

COVID-19
Coronavirus Infections / complications*
Humans
Inflammatory Bowel Diseases / complications*
Inflammatory Bowel Diseases / immunology
Inflammatory Bowel Diseases / therapy*
Pandemics
Pneumonia, Viral / complications*